Non-invasive gamma camera imaging of gene transfer using an adenoviral vector encoding an epitope-tagged receptor as a reporter

Gene Therapy

Volumn 10, Issue 2, 2003, Pages 105-114

  Rogers, B E ^a   Chaudhuri, T R ^b   Reynolds, P N ^c,d   Della Manna, D ^a   Zinn, K R ^b  

^a The University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

99mTc; Gene transfer; Hemagglutinin; Imaging; Somatostatin receptor

Indexed keywords

ADENOVIRUS VECTOR; EPITOPE; FLUORESCEIN ISOTHIOCYANATE; HEMAGGLUTININ; MONOCLONAL ANTIBODY; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; TECHNETIUM 99M;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; CANCER CELL CULTURE; CELL SURFACE; CONTROLLED STUDY; DRUG BINDING; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG UPTAKE; EXPERIMENTAL MODEL; FEASIBILITY STUDY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; FUSION GENE; GENE EXPRESSION; GENE SEQUENCE; GENE TRANSFER; GENETIC CODE; HUMAN; HUMAN CELL; IMAGING SYSTEM; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; LUNG NON SMALL CELL CANCER; MOUSE; NON INVASIVE MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; SCINTILLATION CAMERA; TUMOR LOCALIZATION; TUMOR MODEL; VIRAL GENE DELIVERY SYSTEM; ADENOVIRUS; ANIMAL; CELL LINE; CONFOCAL MICROSCOPY; EXPERIMENTAL NEOPLASM; FEMALE; FLOW CYTOMETRY; GENE THERAPY; GENE VECTOR; GENETIC ENGINEERING; GENETIC TRANSDUCTION; GENETICS; LIVER; METABOLISM; METHODOLOGY; NUDE MOUSE; SCINTISCANNING;

ADENOVIRIDAE; ANIMALIA; DNA VIRUSES;

ADENOVIRIDAE; ANIMALS; CELL LINE; EPITOPES; FEMALE; FLOW CYTOMETRY; GENE THERAPY; GENES, REPORTER; GENETIC ENGINEERING; GENETIC VECTORS; HEMAGGLUTININS; HUMANS; LIVER; MICE; MICE, NUDE; MICROSCOPY, CONFOCAL; NEOPLASMS, EXPERIMENTAL; RADIONUCLIDE IMAGING; RECEPTORS, SOMATOSTATIN; TRANSDUCTION, GENETIC;

EID: 0037264051     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301853     Document Type: Article

References (55)

1. Human gene marker/therapy clinical protocols (complete updated listings). Hum Gene Ther 1999; 10: 3067-3123.
2. Contag CH, Jenkins D, Contag PR, Negrin RS. Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia 2000; 2: 41-52.
3. Lipshutz GS et al. In utero delivery of adeno-associated viral vectors: intraperitoneal gene transfer produces long-term expression. Mol Ther 2001; 3: 284-292.
4. Yang M et al. Visualizing gene expression by whole-body fluorescence imaging. Proc Natl Acad Sci USA 2000; 97: 12 278-12 282.
5. Pfeifer A et al. Transduction of liver cells by lentiviral vectors: analysis in living animals by fluorescence imaging. Mol Ther 2001; 3: 319-322.
6. Chaudhuri TR et al. Light-based imaging of green fluorescent protein-positive ovarian cancer xenografts during therapy. Gynecol Oncol 2001; 82: 581-589.
7. Chaudhuri TR et al. A noninvasive reporter system to image adenoviral-mediated gene transfer to ovarian cancer xenografts. Gynecologic Oncol 2001; 83: 432-438.
8. Weissleder R et al. In vivo magnetic resonance imaging of transgene expression. Nat Med 2000; 6: 351-355.
9. Louie AY et al. In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 2000; 18: 321-325.
10. Stegman LD et al. Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy. Proc Natl Acad Sci USA 1999; 96: 9821-9826.
11. Walter G, Barton ER, Sweeney HL. Noninvasive measurement of gene expression in skeletal muscle. Proc Natl Acad Sci USA 2000; 97: 5151-5155.
12. Auricchio A, Zhou R, Wilson JM, Glickson JD. In vivo detection of gene expression in liver by 31P nuclear magnetic resonance spectroscopy employing creatine kinase as a marker gene. Proc Natl Acad Sci USA 2001; 98: 5205-5210.
13. Gambhir SS et al. Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. J Nucl Med 1998; 39: 2003-2011.
14. Tjuvajev JG et al. A general approach to the non-invasive imaging of transgenes using cis- linked herpes simplex virus thymidine kinase. Neoplasia 1999; 1: 315-320.
15. Tjuvajev JG et al. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo. Cancer Res 1999; 59: 5186-5193.
16. Hospers GA et al. Monitoring of herpes simplex virus thymidine kinase enzyme activity using positron emission tomography. Cancer Res 2000; 60: 1488-1491.
17. Gambhir SS et al. A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc Natl Acad Sci USA 2000; 97: 2785-2790.
18. Gambhir SS, et al. Imaging transgene expression with radio-nuclide imaging technologies. Neoplasia 2000; 2: 118-138.
19. Iyer M et al. 8-18Ffluoropenciclovir: an improved reporter probe for imaging HSV1-tk reporter gene expression in vivo using PET. J Nucl Med 2001; 42: 96-105.
20. 18F]FHPG. Eur J Nucl Med 2001; 28: 5-12.
21. Jacobs A et al. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. Cancer Res 2001; 61: 2983-2995.
22. 2 receptor as a reporter gene in living animals. Gene Ther 1999; 6: 785-791.
23. Liang Q et al. Noninvasive, quantitative imaging in living animals of a mutant dopamine D2 receptor reporter gene in which ligand binding is uncoupled from signal transduction. Gene Ther 2001; 8: 1490-1498.
24. 188Re. J Nucl Med 2000; 41: 887-895.
25. Rogers BE, Zinn KR, Buchsbaum DJ. Gene transfer strategies for improving radiolabeled peptide imaging and therapy. Q J Nucl Med 2000; 44: 208-223.
26. Zinn KR et al. Gamma camera dual imaging with a somatostatin receptor and thymidine kinase after gene transfer with a bicistronic adenovirus in mice. Radiology 2002; 223: 417-425.
27. Yu Y et al. Quantification of target gene expression by imaging reporter gene expression in living animals. Nat Med 2000; 6: 933-937.
28. Boland A et al. Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy. Cancer Res 2000; 60: 3484-3492.
29. Raben D et al. Enhancement of radiolabeled antibody binding and tumor localization through adenoviral transduction of the human carcinoembryonic antigen gene. Gene Ther 1996; 3: 567-580.
30. Zinn KR et al. Simultaneous evaluation of dual gene transfer to adherent cells by gamma-ray imaging. Nucl Med Biol 2001; 28: 135-144.
31. Koller KJ et al. A genetic method for the production of cell lines expressing high levels of 7-transmembrane receptors. Anal Biochem 1997; 250: 51-60.
32. Kundra V, Mannting F, Jones AG, Kassis AI. Noninvasive monitoring of somatostatin receptor subtype 2 chimeric gene transfer. J Nucl Med 2002; 43: 406-412.
33. Zinn KR et al. Detection and measurement of in vitro gene transfer by gamma camera imaging. Gene Ther 2001; 8: 291-299.
34. 1-octreotide. J Nucl Med 1996; 37: 2002-2006.
35. 111In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy. Cancer Res 1998; 58: 437-441.
36. van der Eb MM et al. Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration. Gene Ther 1998; 5: 451-458.
37. Alemany R, Curiel DT. CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors. Gene Ther 2001; 8: 1347-1353.
38. 99mTc-labeled adenovirus knob (serotype 5). Gene Ther 1998; 5: 798-808.
39. Haunschild J, Haro HP, Pack P, Pluckthun A. Pharacokinetic properties of bivalent miniantibodies and comparison to other immunoglobulin forms. Antib Immunoconjugates Radiopharm 1995; 8: 111-128.
40. Slavin-Chiorini DC et al. A CDR-grafted (humanized) domain-deleted antitumor antibody. Cancer Biother Radiopharm 1997; 12: 305-316.
41. Wu AM et al. High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment. Proc Natl Acad Sci USA 2000; 97: 8495-8500.
42. Bousquet C et al. Antiproliferative effect of somatostatin and analogs. Chemotherapy 2001; 47: 30-39.
43. Ferjoux G et al. Signal transduction of somatostatin receptors negatively controlling cell proliferation. J Physiol Paris 2000; 94: 205-210.
44. Rochaix P et al. Gene therapy for pancreatic carcinoma: local and distant antitumor effects after somatostatin receptor sst2 gene transfer. Hum Gene Ther 1999; 10: 995-1008.
45. Fitzpatrick VD, Vandlen RL. Agonist selectivity determinants in somatostatin receptor subtypes I and II. J Biol Chem 1994; 269: 24 621-24 626.
46. Kaupmann K et al. Two amino acids, located in transmembrane domains VI and VII, determine the selectivity of the peptide agonist SMS 201-995 for the SSTR2 somatostatin receptor. EMBO J 1995; 14: 727-735.
47. Liapakis G et al. Identification of ligand binding determinants in the somatostatin receptor subtypes 1 and 2. J Biol Chem 1996; 271: 20 331-20 339.
48. Strnad J, Hadcock JR. Identification of a critical aspartate residue in transmembrane domain three necessary for the binding of somatostatin to the somatostatin receptor SSTR2. Biochem Biophys Res Commun 1995; 3: 913-921.
49. Nehring RB, Meyerhof W, Richter D. Aspartic acid residue 124 in the third transmembrane domain of the somatostain receptor subtype 3 is essential for somatostatin-14 binding. DNA Cell Biol 1995; 14: 939-944.
50. Roth A et al. Endocytosis of the rat sinatistin receptors: subtype discrimination, ligand specificity, and delineation of carboxy-terminal positive and negative sequence motifs. DNA Cell Biol 1997; 16: 111-119.
51. 2 receptors and associated agonists. Biochem J 1998; 336: 2 91-298.
52. Bogadanov JA, Petherick P, Marecos E, Weissleder R. In vivo localization of diglycylcysteine-bearing synthetic peptides by nuclear imaging of oxotechnetate transchelation. Nucl Med Biol 1997; 24: 739-742.
53. He T et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998; 95: 2509-2514.
54. 1-octreotide to human ovarian tumor xenografts induced to express the somatostatin receptor subtype 2 using an adenoviral vector. Clin Cancer Res 1999; 5: 383-393.
55. Zinn KR et al. Imaging Tc-99m-labeled FGF-1 targeting in rats. Nucl Med Biol 2000; 27: 407-414.